Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Regen Network is a technology company that operates a decentralized platform for ecological assets and data. While the name suggests regenerative medicine, the company actually focuses on regenerative agriculture and environmental restoration by using blockchain technology to track and verify ecological improvements. Their platform, Regen Ledger, allows for the creation of carbon credits and other ecological tokens, enabling land stewards to be rewarded for positive environmental impacts. The company provides tools for monitoring, reporting, and verification (MRV) of soil health and biodiversity, serving as a bridge between ecological data and financial markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReGen Network.